You are here: Home » PTI Stories » National » News
Business Standard

Lupin gets USFDA nod to market generic depression drug

Press Trust of India  |  New Delhi 

Tuesday said it has received approval from the US health regulator to market Tablets, used to treat major depressive disorder, in the American market.

The company has received approval from the US Food and Drug Administration(USFDA) to market its product which is a generic version of Eli Lilly and Company's tablets, said in a statement.

The product is also indicated for treatment of obsessive compulsive disorder, and panic disorder, it said.

Shares of were trading up 0.23 per cent at Rs 832.10 apiece on the BSE.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Tue, April 16 2019. 15:20 IST